# MOMENTUM-1 (NCT06955169)

> Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06955169
- Phase: PHASE2
- Status: RECRUITING
- Sponsor: RTOG Foundation, Inc.
- Conditions: Intracranial Meningioma
- Interventions: [177Lu]Lu-DOTATATE; Standard of Care treatments
- Enrollment: 130
- Primary outcome: Progression Free Survival (PFS)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- YouTube: 2
- X threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=momentum-1-nct06955169